DMK PHARMACEUTICALS Corp Annual Earnings Per Share, Diluted in USD/shares from 2012 to 2022

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
DMK PHARMACEUTICALS Corp quarterly/annual Earnings Per Share, Diluted history and growth rate from 2012 to 2022.
  • DMK PHARMACEUTICALS Corp Earnings Per Share, Diluted for the quarter ending September 30, 2023 was -0.2 USD/shares, a 90.2% increase year-over-year.
  • DMK PHARMACEUTICALS Corp Earnings Per Share, Diluted for the twelve months ending September 30, 2023 was 2.2 USD/shares.
  • DMK PHARMACEUTICALS Corp annual Earnings Per Share, Diluted for 2022 was -0.18 USD/shares, a 43.8% increase from 2021.
  • DMK PHARMACEUTICALS Corp annual Earnings Per Share, Diluted for 2021 was -0.32 USD/shares.
  • DMK PHARMACEUTICALS Corp annual Earnings Per Share, Diluted for 2016 was -1.19 USD/shares, a 15.5% decline from 2015.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $0 +$0.14 +43.8% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-16
2021 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2016 -$1 $0 -15.5% Jan 1, 2016 Dec 31, 2016 10-K 2017-03-30
2015 -$1 $0 0% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 -$1 +$0.19 +15.6% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-23
2013 -$1 +$0.01 +0.81% Apr 1, 2013 Mar 31, 2014 10-KT 2015-03-26
2012 -$1 Apr 1, 2012 Mar 31, 2013 10-K 2014-06-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.